Prevention and Control of COVID-19 in Indian Perspective

  • Sujeet Kumar Singh National Centre for Disease Control, Ministry of Health & Family Welfare, 22 Sham Nath Marg, Delhi, India.
  • SK Jain National Centre for Disease Control, Ministry of Health & Family Welfare, 22 Sham Nath Marg, Delhi, India.
  • SN Sharma National Centre for Disease Control, Dte. General of Health Services, Government of India, 22-Sham Nath Marg, Delhi, India.
Keywords: COVID-19, 2019-nCoV, Virus, Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) Coronavirus


The COVID-19 was first identified as the cause of an outbreak of respiratory illness in Wuhan, Hubei Province, China beginning in December 2019 resulting in high morbidity and mortality. This epidemic had spread to almost all the countries of the globe with 202 countries affected with corona virus reporting 722401 cases and 34007 deaths (till 29.3.2020). A total of 159,102 have been reported as recovered. The World Health Organization declared it as a Public Health Emergency of International Concern. The Medical fraternity is struggling hard to gather latest updates and better understanding of the epidemiology, causes, clinical diagnosis, prevention and control of this virus. Studies thus far have shown origination in connection to a seafood market in Wuhan, but specific animal association has not been confirmed. The reported symptoms include fever, cough, fatigue, pneumonia, headache, diarrhea, hemoptysis, and dyspnea. Preventive measures such as masks, hand hygiene practices, avoidance of public contact, case detection, contact tracing and quarantines are effective for reducing the transmission. There is no specific treatment or vaccine which has been proven quite effective. Therefore, infected people are primarily given symptomatic treatment and supportive care with proper isolation and quarantine. Such public health emergencies in the form of pandemic need to be managed with strict social distancing and not allowing Stage 3, which is community transmission. Proper planning of infra-structure, resources, capacity building need be in places under such crucial period to avoid the chances of transmission and mortality.

How to cite this article:
Singh SK, Jain SK, Sharma SN. Prevention and Control of COVID-19 in Indian Perspective. Epidem Int 2020; 5(1): 32-38.



WMHC. Wuhan Municipal Health and Health Commission’s Briefing on the Current Pneumonia

Epidemic Situation in Our City. 2020. showDetail/2019123108989

(accessed on 1 February 2020).

CDC. 2019 Novel Coronavirus, Wuhan, China.

(accessed on 1 February 2020).

WHO. Novel Coronavirus-China.

(accessed on 1 February 2020).

WHO. Novel Coronavirus-Japan (ex-China). (accessed on 1February, 2020). Novel 2019 Coronavirus Genome.

(accessed on 1 February 2020).

Fehr AR, Channappanavar R, Perlman S. Middle East respiratory syndrome: emergence of a pathogenic

human coronavirus. Annual review of medicine 2017; 68: 387-99.

WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency

Committee regarding the outbreak of novel coronavirus (2019-nCoV).


emergency-committee-regarding-the-outbreak-ofnovel-coronavirus-(2019-ncov) (accessed on 1 February


One COVID-19 positive infects 1.7 in India, lower than in hot zones, The Indian Express, 19 March 2020.

“One reason for the relatively slow increase in the number of novel coronavirus patients in India, as of

now, could be the fact that every infected person has been passing on the virus only to another 1.7 people

on an average. This is remarkably lower than what has been observed in the worst-affected countries, a study

by scientists at the Institute of Mathematical Sciences in Chennai shows.”

Jump up to:a b «India Suspends All Tourist Visas Till April 15 Over Coronavirus: 10 Facts».

Retrieved 12 March 2020.

India coronavirus: Modi announces 21-day nationwide lockdown, limiting movement of 1.4 bn people, The

Independent, 24 March 2020.

Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses 2010; 2: 1804-1820.

Drexler JF, Gloza-Rausch F, Glende J, Corman VM, Muth D, Goettsche M et al. Genomic characterization of

severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses

based on partial RNA-dependent RNA polymerase gene sequences. J Virol 2010; 84: 11336-11349.

Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology

; 23: 130-137.

Peiris JSM, Lai ST, Poon L et al. Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet 2003; 361: 1319-1325.

Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from

a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-1820.

Imperial College London. Report 2: estimating the potential total number of novel coronavirus cases in

Wuhan City, China. Jan 2020.



Most read articles by the same author(s)